Targeting the source.
A future where patients with neurological diseases are effectively treated
We are committed to unlocking the full potential of miRNA therapy as a new frontier in the treatment of neurological diseases. With diligence and creativity, we advance promising therapies that harness the power of miRNA biology to effectively treat diseases such as Epilepsy and Parkinson’s.
Building on this commitment, we engage with patients, caregivers and the medical community to ensure we’re working towards outcomes that are truly life changing.

We share our latest development updates, scientific publications and industry perspectives
Investors
Work with us
Interested in joining Neumirna? Explore current career opportunities or contact us to learn how you can contribute to our mission.
